1012 



SUBJECT INDEX 



oxidation of, 



arsenicals, 659, 662, 664-667, 755-756 



arsenite-BAL, 659 



iodoacetate, 89, 93-96 



lewisite, 666 



maleate, 300 



menadiol-diP, 491 

 phosphoroclastic reaction, arsenite, 

 663 



photometabolism of, arsenite, 663 

 Pyruvate carboxylase (pyruvateiCOa li- 



iV-ethylmaleimide, 352 



iodoacetamide, 73 

 Pyruvate decarboxylase, 



iV-alkyl-p-phenylenediamines, 590-591 



alloxan, 399 



p-aminophenol, 590 



arsenicals, 638, 648-649, 653 



iodoacetamide, 92, 272 



iodoacetate, 46, 92, 272 



iodoacetate ethyl ester, 278 



maleate, 298 



naphthoquinones, 572-573 



quinones, 457-458, 465-468 



SH reagent comparison, 813 



silver, 813 

 Pyruvate dehydrogenase, 



arsenicals, 638 



iV-ethylmaleimide, 352 



maleate, 298, 300 

 Pyruvate:indophenol oxidoreductase, ar- 

 senite, 638 

 Pyruvate kinase, 



alloxan, 399 



iodoacetate, 73 

 Pyruvate oxidase, 



arsenicals, 599, 618, 638-639, 645, 651- 



653 



p-benzoquinone, 458, 465 



bromoacetophenone, 282 



catechol, 458 



chloropicrin, 282 



iodoacetamide, 92, 272 



iodoacetate, 48, 88-89, 92, 272, 282 



iodoacetate esters, 278 



maleate, 299 



reaction sequence of, 652 



Qq, see Coenzyme Qq 



Quinhydrone, 432 



Quinine oxidase, menadione, 459 



p-Quinonediimine, see ?)-Benzoquinone- 



diimine 

 Quinone-disulfones, 440 

 p-Quinoneimine, see p-Benzoquinone- 



imine 

 Quinone-mercaptols, 440 

 Quinone reductase, see also NADH:qui- 



none oxidoreductase, 476-477 

 Quinones, see also specific quinones, 



abbreviations for, 423 



active transports, 503-504 



algal growth, 573-574 



autoxidation of, 432-433 



bacterial growth, 543-560 

 biphasic effects, 551-553 

 comparison of gram -f and gram — 

 bacteria, 553 

 factors involved, 551 

 mechanisms involved, 556-559 

 structure-action relations, 553-556 



bacterial infections, 559-560 



bioluminescence, 422, 496-497 



blood pressure, 514-515 



blood vessels, 502 



carcinogenicity of, 539 



carcinostasis, 538-542 



catecholamine metabolism, 502-503 



central nervous system, 506, 512-514 



cercaricidal action, 577 



chemical properties, 423-435 



circulation, 514-515 



determinations of, 435 



electron transport, 470-477 



embryogenesis, 520-526 



enzyme inhibitions, 445-470 

 historical, 422-423 

 mechanisms involved, 445, 462 

 oxidation of enzyme groups, 462-463 

 pH effects, 469-470 

 rates of inhibition, 468-469 

 reactive form of quinones, 464-466 

 relation to SH groups, 463-464 

 structure-action relations, 466-467 



